| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72ec7aad212526c2a236623138c9fb6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b432b53ab20a7a15376117405050e4d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66bd9852835de9df5029cf99a2aae33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f434ec3efe9ff15955718ecb164f58f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_709ed71f9f47f0b67eaf69ef0cbd70ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b778414ca3795bc1e97d1e6ef3c17ef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410d7c5e539f4b33537b0a0e068a212a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96677333c4bcad0a9e261cec1f9921d8 |
| publicationDate |
2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2177349-C1 |
| titleOfInvention |
Method for treating the cases of infiltrating edematous mammary gland cancer |
| abstract |
FIELD: medicine. SUBSTANCE: method involves administering regional and systemic chemotherapy with artery feeding the tumor being embolized and radiation treatment applied immediately after the chemoembolism. This radiation chemotherapy is to be applied on the background of prednisolone treatment administered to the patient. Radiation treatment is administered in the medium fractionation of a dose in 3 Gr 5 times a week until total dose of 45 Gr when applied to mammary gland base, and 33-36 Gr in usually applied fractionation method when directed to regional lymph circulation zones, is achieved. Traditional chemotherapy is administered after accomplishing the treatment course. EFFECT: enhanced effectiveness of treatment; lower toxic influence of the chemical preparations. 2 cl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2550663-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2637859-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9795672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2519669-C2 |
| priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |